|
Mouse Studies |
Model |
|
| |
|
Peter Rabinovitch (Nathan Shock Center, University of Washington) |
|
mCAT tr (reduced oxidative stress) polG tr (increased mtDNA mutations) |
| |
|
|
Holly Van Remmen (Barshop Center for Longevity, Nathan Shock Center, UTHSCSA) |
|
SOD1 KO (increased oxidative stress) |
| |
|
|
Stanley Froehner (University of Washington) |
|
nNOS tr (muscular dystrophy) |
| |
|
|
Mary-Ellen Harper (University of Ottawa) |
|
UCP3 KO (mitochondrial P/O) |
| |
|
|
Hazel Szeto (Cornell University) |
|
Mitochondrially targeted antioxidants (SS peptides) |
| |
|
|
Joachim Voss (University of Washington) |
|
AZT treatment |
| |
|
|
Human Studies |
Model |
| |
|
Jonathan Himmelfarb (University of Washington) |
|
Kidney failure patients (oxidative stress) |
| |
|
Karen Syrjala (Fred Hutchinson Cancer Research Center) |
|
Post-cancer treatment survivors (fatigue) |
| |
|
Marco Pahor (University of Florida, Institute on Aging) |
|
Elderly human Resveratrol treatment |
| |
|
Luigi Ferrucci (National Institutes of Aging: Baltimore Long. Study) |
|
Aging population (Aging mechanisms) |
| |
|
Bret Goodpaster (University of Pittsburgh) |
|
Obesity and Aging |
| |
|
Steve Smith (Pennington Biomedical Research Center) |
|
Human calorie restriction |